CX3CL1 and Alzheimer disease: The levels of both CX3CL1 and CX3CR1 were found to be significantly lower in the hippocampus and frontal cortices of AD brains than in those of controls (Cho et al., 2011), indicating an impairment of CX3CL1/CX3CR1 signaling in AD.